Neonatal Abstinence Syndrome: Taking Care of Mom and Baby Heather Rodman, PharmD PGY-2 Pediatric...
-
Upload
emily-marcon -
Category
Documents
-
view
223 -
download
0
Transcript of Neonatal Abstinence Syndrome: Taking Care of Mom and Baby Heather Rodman, PharmD PGY-2 Pediatric...
Neonatal Abstinence Syndrome: Taking Care of Mom and Baby
Heather Rodman, PharmDPGY-2 Pediatric Pharmacy ResidentPeyton Manning Children’s Hospital
St. Vincent Hospital and Health ServicesSeptember 2014
This speaker has no actual or potential conflicts of interest to disclose in relation to this presentation.
2
Definition
• Withdrawal after prenatal exposure to certain drugs
• Dysregulation of the central, autonomic, and gastrointestinal functioning of the neonate
Hudak, ML, et al. Pediatrics. 2012; 129: e540-e560.Sutter MB, et al. Obstet Gynecol Clin N Am. 2014; 41: 317-334.Logan BA, et al. Clin Obstet Gynecol. March 2013; 56(1): 186-192.
Drug Estimated Onset of Signs/ SymptomsOpioids 24-72 hours, up to 7 days pending half-life
Benzodiazepines hours – weeksAlcohol 3-12 hours
3
Signs / Symptoms
Central Nervous System Autonomic Gastrointestinal
Irritability Temperature instability
Poor feeding & weight gain
High pitched crying Nasal stuffiness Uncoordinated sucking
Tremors & seizures Sweating Diarrhea & diaper rash
Hudak, ML, et al. Pediatrics. 2012; 129: e540-e560.Sutter MB, et al. Obstet Gynecol Clin N Am. 2014; 41: 317-334.Logan BA, et al. Clin Obstet Gynecol. March 2013; 56(1): 186-192.
5
Prenatal Care
• Enrollment in an opioid maintenance program• Minimizes cravings and optimizes maternal health• Prevents fetal stress and suppresses withdrawal• Anticipatory neonatal withdrawal
• Methadone is most commonly chosen• Buprenorphine may shorten treatment duration and hospital stay of the neonate• Increased dropout rate with buprenorphine
• Increased doses may be required during 3rd trimester
Hudak, ML, et al. Pediatrics. 2012; 129: e540-e560.Logan BA, et al. Clin Obstet Gynecol. March 2013; 56(1): 186-192.Jones HE, et al. NEJM. Dec 2010; 363(24): 2320-2331.
6
Addiction Resources
• Indiana Addictions Issues Coalition (IAIC)• http://recoveryindiana.org/index.php
• United States Recovery• List of support groups and treatment centers by state• http://www.usrecovery.info/index.htm
• National Institute on Drug Abuse (NIH)• Resources for professionals, patients, and families• http://www.drugabuse.gov/
• National Council on Alcoholism and Drug Dependence• http://ncadd.org/index.php
• American Congress of Obstetricians and Gynecologists (ACOG)• http://www.acog.org/Patients/FAQs/Tobacco-Alcohol-Drugs-and-Pregnancy
8
Non-Pharmacologic Measures
• Dark, quiet environment• Swaddling and comforting techniques• Swaying, rocking• Skin-to-skin contact (parents only)• Music therapy
• Small but frequent feedings• Breast feeding approved by AAP• Contraindications: HIV (+) • Relative contraindications: Hepatitis C (+), heroin, cocaine, alcohol abuse
• Family education
Hudak, ML, et al. Pediatrics. 2012; 129: e540-e560.Sutter MB, et al. Obstet Gynecol Clin N Am. 2014; 41: 317-334.
9
Pharmacologic Treatment Options
Langenfeld S, et al. Drug Alcohol Depend. 2005; 77(1): 31-36.Agthe AG, et al. Pediatrics. May 2009; 123(5): e849-e856.Kraft WK, et al. Pediatr Clin N Am. 2012; 59: 1147-1165.Hudak, ML, et al. Pediatrics. 2012; 129: e540-e560.Sutter MB, et al. Obstet Gynecol Clin N Am. 2014; 41: 317-334.
Primary Pharmacologic OptionsDrug Neonatal Dosing (oral) Comments
Diluted Tincture of Opium (DTO)
- No longer common practice
Morphine 0.03-0.1 mg/kg/dose Q3-4HWean by: 10-20%
pending s/sx
Equally efficacious as DTO
Methadone 0.05-0.1 mg/kg/dose Q6-24HWean by: 10-20%
pending s/sx
Longer half-life than morphine
Sublingual Buprenorphine
Dosing not established Requires additional studies
10
Langenfeld S, et al. Drug Alcohol Depend. 2005; 77(1): 31-36.Agthe AG, et al. Pediatrics. May 2009; 123(5): e849-e856.Kraft WK, et al. Pediatr Clin N Am. 2012; 59: 1147-1165.Hudak, ML, et al. Pediatrics. 2012; 129: e540-e560.Sutter MB, et al. Obstet Gynecol Clin N Am. 2014; 41: 317-334.
Adjuvant Therapy
Drug Neonatal Dosing (oral) Comments
Phenobarbital Load: 16 mg/kg day 1Maintenance: 1-4 mg/kg/dose
Q12HWean by: 20% every other day
Fallen out of favor due to cognitive
behavioral effects
Clonidine ≥ 35 week gestation: 0.5-1 mcg/kg Q4-6H
Weaning not established
Not as well studied as
phenobarbital
11
Long-Term Outcomes
• Difficult to evaluate• Confounding variables
• Withdrawal seizures respond to opiates and do not necessarily carry an increased risk of poor outcomes
• Neurocognitive delays possible during infancy• Working memory updating - Resolved at ~ 7 months• Regulation and quality of movement• Excitability• Delay in milestones: Independent sitting, crawling
Hudak, ML, et al. Pediatrics. 2012; 129: e540-e560.Sutter MB, et al. Obstet Gynecol Clin N Am. 2014; 41: 317-334.Logan BA, et al. Clin Obstet Gynecol. March 2013; 56(1): 186-192.
12
Take Home Points
• Pregnant women on methadone may require higher doses during pregnancy
• Buprenorphine is now considered a safe, alternative option for pregnant women enrolled in an opioid maintenance program
• Breastfeeding is beneficial for NAS even while the mom is still enrolled in the maintenance program
13
Assessment Question
• During which trimester is a pregnant woman most likely to require her highest dose of methadone?A. 1st TrimesterB. 2nd TrimesterC. 3rd Trimester